Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 27, 2015 6:46 PM ET

Pharmaceuticals

Company Overview of Theravance Inc.

Executive Profile

George B. Abercrombie R.Ph., MBA

Senior Vice President of Corporate Partnerships & Commercial, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 10 different industries.

See Board Relationships
59$1,899,507
As of Fiscal Year 2014

Background

Mr. George B. Abercrombie, R.Ph., MBA, has been Senior Vice President of Corporate Partnerships & Commercial at Theravance Inc. since June 2014. Mr. Abercrombie has more than 30 years experience as a Business Leader in the pharmaceutical industry. He has substantial expertise in sales and marketing, executive sales management and business development. Mr. Abercrombie served as the Chief Executive Officer and President of Roche Laboratories, Inc. Mr. Abercrombie served ...

Corporate Headquarters

951 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-238-9600
Fax: --

Board Members Memberships

Former Director
Director
2010-Present
Director and Member of Audit Committee
2010-2010
Former Director, Member of Nominating Committee, Member of Compensation Committee and Member of Nominating and Corporate Governance Committee
2011-Present
Non-Executive Chairman, Member of Audit Committee, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
2011-N/A
Director and Member of Nominating & Corporate Governance Committee
2013-Present
Director

Education

MBA
Harvard Business School
BS
University Of North Carolina At Chapel Hill

Other Affiliations

Annual Compensation

Salary$219,167
Total Annual Compensation$219,167

Stocks Options

Restricted Stock Awards$293,200
All Other Compensation$500
Unexercisable Options$100,000
Total Number of Options$100,000

Total Compensation

Total Annual Cash Compensation$389,667
Total Short Term Compensation$219,167
Other Long Term Compensation$293,700
Total Calculated Compensation$1,899,507
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
$440.2K
Richard Martin Steeves Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
$823.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Theravance Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.